Avadel Pharmaceuticals (AVDL) Current Assets: 2009-2022
Historic Current Assets for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Sep 2022 value amounting to $113.2 million.
- Avadel Pharmaceuticals' Current Assets fell 44.99% to $113.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $113.2 million, marking a year-over-year decrease of 44.99%. This contributed to the annual value of $192.5 million for FY2021, which is 26.94% down from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Current Assets of $113.2 million as of Q3 2022, which was down 9.94% from $125.7 million recorded in Q2 2022.
- In the past 5 years, Avadel Pharmaceuticals' Current Assets registered a high of $281.7 million during Q3 2020, and its lowest value of $82.4 million during Q4 2019.
- For the 3-year period, Avadel Pharmaceuticals' Current Assets averaged around $202.2 million, with its median value being $205.8 million (2021).
- Per our database at Business Quant, Avadel Pharmaceuticals' Current Assets slumped by 55.83% in 2019 and then surged by 219.80% in 2020.
- Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Current Assets stood at $124.9 million in 2018, then plummeted by 34.02% to $82.4 million in 2019, then skyrocketed by 219.80% to $263.5 million in 2020, then declined by 26.94% to $192.5 million in 2021, then slumped by 44.99% to $113.2 million in 2022.
- Its last three reported values are $113.2 million in Q3 2022, $125.7 million for Q2 2022, and $160.7 million during Q1 2022.